In 2026, China’s leading organosilicon producers significantly increased R&D spending to meet downstream demands for high-performance materials. Annual reports show Hoshine, Wynca, and Dongyue raised R&D expenses by over 25% in 2025, with R&D intensity reaching 3.5%–4.8% of revenue (over 6% for specialty subsidiaries)—approaching global peer levels.
Focus areas include: new energy materials (800V-insulating, flame-retardant battery sealants); electronics (low-alpha silicone oils for semiconductors, dielectric rubbers for 5G); and biomedical (high-purity gels, degradable composites). Jingxin’s new “Organosilicon Functional Materials Institute” (launched 2026) employs over 100 researchers focused on fluorosilane synthesis and platinum catalyst recovery.
Policy support is strong. The Ministry of Science and Technology allocated over RMB 120 million in 2025 for the “Key Technologies for High-End Organosilicon Materials” national project. The First-Batch New Materials Insurance Compensation Mechanism now covers medical- and electronic-grade silicones, reducing customer trial risk.
